Sign In
Buy ADCT
$1.15
+0.0600 (+5.50%)
At Close: Jun 23, 2026
ADC Therapeutics SA (ADCT) Reports Q1 Loss, Misses Revenue Estimates
09:57am, Tuesday, 09'th May 2023
ADC Therapeutics SA (ADCT) came out with a quarterly loss of $0.74 per share versus the Zacks Consensus Estimate of a loss of $0.80. This compares to loss of $0.36 per share a year ago.
ADC Therapeutics to Host First Quarter 2023 Financial Results Conference Call on May 9, 2023
07:15am, Tuesday, 02'nd May 2023
LAUSANNE, Switzerland--(BUSINESS WIRE)--ADC Therapeutics SA (NYSE: ADCT) today announced that it will host a conference call and live webcast on Tuesday, May 9, 2023 at 8:30 a.m. EDT to report financi
Down -36.18% in 4 Weeks, Here's Why ADC Therapeutics SA (ADCT) Looks Ripe for a Turnaround
11:18am, Tuesday, 07'th Mar 2023
ADC Therapeutics SA (ADCT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings
ADC Therapeutics SA (ADCT) Q4 2022 Earnings Call Transcript
07:20pm, Tuesday, 28'th Feb 2023
ADC Therapeutics SA (NYSE:ADCT ) Q4 2022 Results Conference Call February 28, 2023 8:30 AM ET Company Participants Amanda Hamilton - IR Manager Ameet Mallik - CEO Kristen Harrington-Smith - Chief Comm
ADC Therapeutics SA (ADCT) Reports Q4 Loss, Misses Revenue Estimates
09:48am, Tuesday, 28'th Feb 2023
ADC Therapeutics SA (ADCT) delivered earnings and revenue surprises of 38.78% and 7.58%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
ADC Therapeutics to Host Fourth Quarter and Year-End 2022 Financial Results Conference Call on February 28, 2023
07:15am, Tuesday, 21'st Feb 2023
LAUSANNE, Switzerland--(BUSINESS WIRE)--ADC Therapeutics SA (NYSE: ADCT) today announced that it will host a conference call and live webcast on Tuesday, February 28, 2023 at 8:30 a.m. ET to report fi
Molina (MOH) to Post Q4 Earnings: What You Should Expect
05:01pm, Monday, 06'th Feb 2023 Zacks Investment Research
Molina Healthcare's (MOH) fourth-quarter results are likely to reflect growth in premiums and Investment income.
Can Lower Managed Care Profits Hurt Centene (CNC) Q4 Earnings?
09:40pm, Friday, 03'rd Feb 2023 Zacks Investment Research
Centene's (CNC) fourth-quarter results are likely to reflect growth in premiums and memberships.
ADC Therapeutics to Participate in February Investor Conferences
07:15am, Wednesday, 01'st Feb 2023
LAUSANNE, Switzerland--( BUSINESS WIRE )--ADC Therapeutics SA (NYSE: ADCT) announced today that Ameet Mallik, Chief Executive Officer, will participate in two investor conferences in February.
Pliant Therapeutics (PLRX) Surges 44% in A Week: Here's Why
03:21pm, Wednesday, 25'th Jan 2023 Zacks Investment Research
Shares of Pliant Therapeutics (PLRX) have been rising since management reported positive interim data from a mid-stage study evaluating a higher dose of its lead pipeline candidate in IPF patients.
Amarin Corporation (AMRN) Down 13% in One Week: Here's Why
04:01pm, Monday, 23'rd Jan 2023 Zacks Investment Research
Shares of Amarin Corporation (AMRN) fell last week as the company's largest shareholder pressurizes the company to make changes to its board of directors.
Wall Street Analysts Think ADC Therapeutics SA (ADCT) Could Surge 174.2%: Read This Before Placing a Bet
02:55pm, Monday, 16'th Jan 2023 Zacks Investment Research
The mean of analysts' price targets for ADC Therapeutics SA (ADCT) points to a 174.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement a
Wall Street Analysts Think ADC Therapeutics SA (ADCT) Could Surge 174.2%: Read This Before Placing a Bet
11:17am, Monday, 16'th Jan 2023
The mean of analysts' price targets for ADC Therapeutics SA (ADCT) points to a 174.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement a
ADC Therapeutics SA (ADCT) Stock Jumps 21.8%: Will It Continue to Soar?
12:28pm, Friday, 13'th Jan 2023 Zacks Investment Research
ADC Therapeutics SA (ADCT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more
Tesla And Other Big Stocks Moving Lower In Friday's Pre-Market Session
11:21am, Friday, 13'th Jan 2023 Benzinga
U.S. stock futures traded mixed this morning. Here are some big stocks recording losses in today’s pre-market trading session.
AGBA Group Holding Limited (NASDAQ: AGBA) shares dropped 13.1% to $4.5
